Sign in

CIK 0001824293 · <br>Emerging growth company

GRI Bio, Inc.

Sign in to watch
Ticker
GRI
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
824369909
Phone
(619) 400-1171
Business address
2223 AVENIDA DE LA PLAYA, SUITE 208, LA JOLLA, CA, 92037
Former names
Vallon Pharmaceuticals, Inc.
  1. DEFA14A Proxy Proxy Materials
  2. EFFECT Other Notice of Effectiveness
  3. EFFECT Other Notice of Effectiveness
  4. ARS Other Annual Report to Security Holders
  5. DEFA14A Proxy Proxy Materials
  6. D Other Notice of Sales of Unregistered Securities
  7. DEFA14A Proxy Proxy Materials
  8. DEFA14A Proxy Proxy Materials
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. EFFECT Other Notice of Effectiveness
  13. EFFECT Other Notice of Effectiveness
  14. EFFECT Other Notice of Effectiveness
  15. DEFA14A Proxy Proxy Materials
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  18. EFFECT Other Notice of Effectiveness
  19. S-1MEF Other S-1MEF
  20. CERT Other Certification

Page 2 of 3 · 44 filings